Company number 10102485
Status Active
Incorporation Date 5 April 2016
Company Type Private Limited Company
Address 4 MALDON CLOSE, LONDON, ENGLAND, E15 1PR
Home Country United Kingdom
Nature of Business 82990 - Other business support service activities n.e.c.
Phone, email, etc
Since the company registration six events have happened. The last three records are Confirmation statement made on 5 April 2017 with updates; Termination of appointment of Muhammed Ashraf as a director on 26 April 2016; Appointment of Mr Muhammed Ashraf as a director on 5 April 2016. The most likely internet sites of ASH PHARMACUETICALS LIMITED are www.ashpharmacueticals.co.uk, and www.ash-pharmacueticals.co.uk. The predicted number of employees is 1 to 10. The company’s age is nine years and eight months. Ash Pharmacueticals Limited is a Private Limited Company.
The company registration number is 10102485. Ash Pharmacueticals Limited has been working since 05 April 2016.
The present status of the company is Active. The registered address of Ash Pharmacueticals Limited is 4 Maldon Close London England E15 1pr. . ASHRAF, Muhammed is a Director of the company. Director ASHRAF, Muhammed has been resigned. The company operates in "Other business support service activities n.e.c.".
Current Directors
Resigned Directors
Director
ASHRAF, Muhammed
Resigned: 26 April 2016
Appointed Date: 05 April 2016
52 years old
Persons With Significant Control
Mr Muhammed Ashraf
Notified on: 6 April 2016
52 years old
Nature of control: Ownership of shares – 75% or more
ASH PHARMACUETICALS LIMITED Events
07 Apr 2017
Confirmation statement made on 5 April 2017 with updates
26 Apr 2016
Termination of appointment of Muhammed Ashraf as a director on 26 April 2016
25 Apr 2016
Appointment of Mr Muhammed Ashraf as a director on 5 April 2016
06 Apr 2016
Registered office address changed from 4 Maldon Close London Essex E15 1PR England to 4 Maldon Close London E15 1PR on 6 April 2016
06 Apr 2016
Director's details changed for Muhammed Ashraf on 6 April 2016
05 Apr 2016
Incorporation
Statement of capital on 2016-04-05